Soluble epoxide hydrolase inhibition prevents coronary endothelial dysfunction in renovascular hypertension

被引：0
|
作者：
Gao, J. [1 ]
Gomez, E. [1 ]
Henry, J. P. [1 ]
Dautreaux, B. [1 ]
Bounoure, F. [3 ]
Skiba, M. [3 ]
Thuillez, C. [1 ,2 ]
Bellien, J. [1 ,2 ]
Richard, V. [1 ,2 ]
机构：
[1] INSERM, U644, F-75654 Paris 13, France
[2] Rouen Univ Hosp, Dept Pharmacol, Inst Biomed Res, Rouen, France
[3] Univ Rouen, ADEN EA 3234, Galen Lab, F-76821 Mont St Aignan, France
来源：
FUNDAMENTAL & CLINICAL PHARMACOLOGY | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
100
引用
收藏
页码：21 / 21
页数：1
相关论文
共 50 条
  • [31] Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage
    Zhao, XY
    Yamamoto, T
    Newman, JW
    Kim, IH
    Watanabe, T
    Hammock, BD
    Stewart, J
    Pollock, JS
    Pollock, DM
    Imig, JD
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2004, 15 (05): : 1244 - 1253
  • [32] Inhibition of the soluble epoxide hydrolase attenuates monocrotaline-induced pulmonary hypertension in rats
    Revermann, Marc
    Barbosa-Sicard, Eduardo
    Dony, Eva
    Schermuly, Ralph T.
    Morisseau, Christophe
    Geisslinger, Gerd
    Fleming, Ingrid
    Hammock, Bruce D.
    Brandes, Ralf P.
    JOURNAL OF HYPERTENSION, 2009, 27 (02) : 322 - 331
  • [33] Inhibition of Soluble Epoxide Hydrolase Increases Coronary Flow and Improves Cardiac Work in Mice
    Qin, Jun
    Jiang, Houli
    Kandhi, Sharath
    Froogh, Ghezal
    Thompson, Carl
    Huang, An
    Sun, Dong
    FASEB JOURNAL, 2015, 29
  • [34] Soluble epoxide hydrolase inhibition in angiotensin II and nitric oxide synthase inhibition-induced hypertension
    Hercule, Hantz C.
    Schunck, Wolf-Hagen
    Gross, Volkmar
    Sausbier, Matthias
    Ruth, Peter
    Luft, Friedrich C.
    Gollasch, Maik
    Volhard, Franz
    HYPERTENSION, 2007, 50 (04) : E139 - E139
  • [35] Soluble epoxide hydrolase inhibition in angiotensin II and nitric oxide synthase inhibition-induced hypertension
    Hercule, H. C.
    Schunck, W. H.
    Gross, V
    Sausbier, U.
    Sausbier, M.
    Weldon, S. M.
    Ruth, P.
    Luft, F. C.
    Gollasch, M.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2007, 132 (46) : S2 - S2
  • [36] Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase
    Alan R. Parrish
    Gang Chen
    Robert C. Burghardt
    Takaho Watanabe
    Christophe Morisseau
    Bruce D. Hammock
    Cell Biology and Toxicology, 2009, 25 : 217 - 225
  • [37] Prevention of cancer cachexia by inhibition of soluble epoxide hydrolase
    Bayer, Rachel L.
    Virani, Sarina
    Gillespie, Michael
    Capuano, Jacqueline
    Smith, Keira
    Quinlivan, Katherine
    Vasquez, Kimberly
    Yang, Jun
    Yang, Haixia
    Mitsiades, Nicholas
    Hammock, Bruce D.
    Panigrahy, Dipak
    CANCER RESEARCH, 2024, 84 (06)
  • [38] Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase
    Parrish, Alan R.
    Chen, Gang
    Burghardt, Robert C.
    Watanabe, Takaho
    Morisseau, Christophe
    Hammock, Bruce D.
    CELL BIOLOGY AND TOXICOLOGY, 2009, 25 (03) : 217 - 225
  • [39] Inhibition of the soluble epoxide hydrolase attenuates diabetic retinopathy
    Hu, J.
    Dziumbla, S.
    Lin, J.
    Bibli, S. I.
    Devraj, K.
    Liebner, S.
    Hammes, H. P.
    Popp, R.
    Fleming, I.
    CARDIOVASCULAR RESEARCH, 2018, 114 : S96 - S96
  • [40] Evaluation of fish models of soluble epoxide hydrolase inhibition
    Newman, JW
    Denton, DL
    Morisseau, C
    Koger, CS
    Wheelock, CE
    Hinton, DE
    Hammock, BD
    ENVIRONMENTAL HEALTH PERSPECTIVES, 2001, 109 (01) : 61 - 66
12345